• Korro Bio director Jean Francois Formela reported selling 2,860 shares of common stock on May 28, 2026.
• Sales were priced at USD 13.95 per share.
• Holdings after the transactions totaled 939,634 shares and 194,655 shares, both reported as indirect ownership.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001030575-26-000002), on June 01, 2026, and is solely responsible for the information contained therein.